Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001655758 | SCV001724451 | benign | not provided | 2025-01-14 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV001655758 | SCV001869884 | benign | not provided | 2019-09-12 | criteria provided, single submitter | clinical testing | |
| Genome- |
RCV003232370 | SCV002054859 | benign | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002439210 | SCV002753086 | likely benign | Inborn genetic diseases | 2018-01-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Ce |
RCV001655758 | SCV004158076 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | NSD1: BP4, BP7 |
| Prevention |
RCV003956173 | SCV004766630 | likely benign | NSD1-related disorder | 2019-07-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |